Pomalidomide-PEG2-COOH
Biomedicine 2025-03-04
CAS NO.: 2140807-17-4
Product purity: ≥95%
Molecular formula: C20H23N3O8
Molecular weight: 433.41
Product Usage: Used in medical research, drug release, nanotechnology and new material research, cell culture. As well as in ligand research, peptide synthesis support, grafted polymer compounds, new materials and polyethylene glycol modified functional coatings and other active compounds.
Basic Information of Pomalidomide-PEG2-COOH
| Item | Information |
|---|---|
| Chemical Name | Pomalidomide-PEG2-COOH |
| CAS Number | 2140807-17-4 |
| Molecular Formula | C₂₀H₂₃N₃O₈ |
| Molecular Weight | 433.41 |
| Appearance | White to yellow powder or crystals |
| Storage Conditions | Powder: -20°C for 3 years; In solvent: -80°C for 1 year |
Additional Information of Pomalidomide-PEG2-COOH
| Item | Information |
|---|---|
| Synonyms | Pomalidomide-PEG2-CO₂H, Pomalidomide 4′-PEG2-acid, Pomalidomide-PEG2-C₂-acid |
| Solubility | DMSO: 200 mg/mL (461.5 mM), sonification recommended |
| Application | Used in PROTAC technology as an E3 ligase ligand-linker conjugate; also used in medical research, drug release, nanotechnology, and polymer modification |
| Purity | ≥95% |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
